WCG, PCCTC partner to improve oncology research reviews

Tuesday, September 29, 2015

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, have formed a new partnership to enhance the quality and efficiency of the consortium’s research review process.

[Read More]

Epic Sciences, Prostate Cancer Clinical Trials Consortium collaborate

Monday, March 9, 2015

Epic Sciences, a San Diego, Calif.-based developer of novel diagnostics to personalize and advance the treatment and management of cancer, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a consortium for phase I/II and phase II clinical trials in prostate cancer, will collaborate to apply Epic’s circulating tumor cell (CTC) technology in multiple investigator-initiated clinical trials to advance the development of new prostate cancer treatments.

[Read More]